|
Brief Reports
Citations 51-60 of 1234 total displayed.
|
Past content
(since Jul 1999):
|
Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease
- Leonardo Magro, Mohamad Mohty, Benoit Catteau, Valérie Coiteux, Patrice Chevallier, Louis Terriou, Jean-Pierre Jouet, and Ibrahim Yakoub-Agha
Blood 2009; 114: 719-722.
[Abstract]
[Full text]
[PDF]
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin
- Sarit Assouline, Biljana Culjkovic, Eftihia Cocolakis, Caroline Rousseau, Nathalie Beslu, Abdellatif Amri, Stephen Caplan, Brian Leber, Denis-Claude Roy, Wilson H. Miller, Jr, and Katherine L. B. Borden
Blood 2009; 114: 257-260.
[Abstract]
[Full text]
[PDF]
Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia
- Alfonso Quintás-Cardama, Xin Han, Hagop Kantarjian, and Jorge Cortes
Blood 2009; 114: 261-263.
[Abstract]
[Full text]
[PDF]
Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies
- Qing Lan, Lindsay M. Morton, Bruce Armstrong, Patricia Hartge, Idan Menashe, Tongzhang Zheng, Mark P. Purdue, James R. Cerhan, Yawei Zhang, Andrew Grulich, Wendy Cozen, Meredith Yeager, Theodore R. Holford, Claire M. Vajdic, Scott Davis, Brian Leaderer, Anne Kricker, Maryjean Schenk, Shelia H. Zahm, Nilanjan Chatterjee, Stephen J. Chanock, Nathaniel Rothman, and Sophia S. Wang
Blood 2009; 114: 264-267.
[Abstract]
[Full text]
[PDF]
Endogenous IL-17 contributes to reduced tumor growth and metastasis
- Ilona Kryczek, Shuang Wei, Wojciech Szeliga, Linhua Vatan, and Weiping Zou
Blood 2009; 114: 357-359.
[Abstract]
[Full text]
[PDF]
Increased frequency (12%) of circulating chronic lymphocytic leukemia–like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach
- Wendy G. Nieto, Julia Almeida, Alfonso Romero, Cristina Teodosio, Antonio López, Ana F. Henriques, Maria Luz Sánchez, María Jara-Acevedo, Ana Rasillo, Marcos González, Paulino Fernández-Navarro, Tomás Vega, Alberto Orfao, and the Primary Health Care Group of Salamanca for the Study of MBL
Blood 2009; 114: 33-37.
[Abstract]
[Full text]
[PDF]
The relationship between the serum free light chain assay and serum immunofixation electrophoresis, and the definition of concordant and discordant free light chain ratios
- Seema Singhal, Eric Vickrey, Jairam Krishnamurthy, Veerpal Singh, Sharon Allen, and Jayesh Mehta
Blood 2009; 114: 38-39.
[Abstract]
[Full text]
[PDF]
Expression of Scl in mesoderm rescues hematopoiesis in the absence of Oct-4
- Kimi Y. Kong, Elizabeth A. Williamson, Jason H. Rogers, Tam Tran, Robert Hromas, and Richard Dahl
Blood 2009; 114: 60-63.
[Abstract]
[Full text]
[PDF]
Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome
- Pietro Luigi Poliani, Fabio Facchetti, Maria Ravanini, Andrew Richard Gennery, Anna Villa, Chaim M. Roifman, and Luigi D. Notarangelo
Blood 2009; 114: 105-108.
[Abstract]
[Full text]
[PDF]
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
- Omar Abdel-Wahab, Ann Mullally, Cyrus Hedvat, Guillermo Garcia-Manero, Jay Patel, Martha Wadleigh, Sebastien Malinge, JinJuan Yao, Outi Kilpivaara, Rukhmi Bhat, Kety Huberman, Sabrena Thomas, Igor Dolgalev, Adriana Heguy, Elisabeth Paietta, Michelle M. Le Beau, Miloslav Beran, Martin S. Tallman, Benjamin L. Ebert, Hagop M. Kantarjian, Richard M. Stone, D. Gary Gilliland, John D. Crispino, and Ross L. Levine
Blood 2009; 114: 144-147.
[Abstract]
[Full text]
[PDF]
|
|
